Ovixan 1 mg/g, Crème

7680655250024 CH-65525 Crème
Ovixan 1 mg/g, Crème
Ovixan 1 mg/g, Crème
Ovixan 1 mg/g, Crème
1 / 3
google

Article details

Package size
100
Selling units
100
Measure
g
Galenic form
Crème
Galenic group
Salben

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
21/07/2022
Patient information leaflet
Français
21/07/2022
Patient information leaflet
Italien
21/07/2022
Summary of Product Characteristics
Allemand
21/07/2022
Summary of Product Characteristics
Français
21/07/2022
Summary of Product Characteristics
Italien
21/07/2022

Detailed composition

Substance Quantity Type Category
(N/A)
1.0 MG Substance WIZUS
(N/A)
0.82 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
70.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
250.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 31.60
Specialties list
Yes
Generic
No
SL addition date: 01/05/2016

Authorization holder

Gebro Pharma AG

4410 Liestal

Authorization information

Swissmedic authorization number
65525
Drug name
Ovixan, Crème
Galenic form
CREM
ATC Code
D07AC13
Authorization status
Z
Dispensing category
B
First authorization
27/10/2015
Authorization expiration date
31/12/9999
IT Number
10.05.1.
Domain
Human medicine
Field of application
kortikoidempfindliche, nichtinfektiöse Dermatosen, chronische Dermatosen wie Psoriasis und atopische Dermatitis (Neurodermatitis)

Package details

Description (FR)
OVIXAN crème 1 mg/g tb 100 g
Description (DE)
OVIXAN Creme 1 mg/g Tb 100 g
Market launch
27/10/2015
Narcotic (BTM)
No

Other package sizes (1)

OVIXAN crème 1 mg/g tb 30 g
30 G
GTIN: 7680655250017
View